Phase I study demonstrates activity and tolerability of diphtheria toxin interleukin-3 fusion protein in patients with AML and MDS

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Frankel, AE; Smith, ER; George, TA; Liu, JS; Lee, J; Park, SK; Rizzieri, DA; Hogge, DE

Published Date

  • November 16, 2007

Published In

Volume / Issue

  • 110 / 11

Start / End Page

  • 273A - 273A

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 49th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • Atlanta, GA

Conference Start Date

  • December 8, 2007

Conference End Date

  • December 11, 2007